PubRank

Barry M Lester

Author PubWeight™ 86.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Smoking during pregnancy and newborn neurobehavior. Pediatrics 2003 2.93
2 Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005 2.26
3 The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006 1.98
4 Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 2007 1.90
5 The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004 1.61
6 Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr 2013 1.61
7 Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012 1.58
8 Impact of prenatal exposure to cocaine and tobacco on diffusion tensor imaging and sensation seeking in adolescents. J Pediatr 2011 1.53
9 Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol 2005 1.52
10 Longitudinal study of maternal report of sleep problems in children with prenatal exposure to cocaine and other drugs. Behav Sleep Med 2009 1.42
11 Assessment of infant cry: acoustic cry analysis and parental perception. Ment Retard Dev Disabil Res Rev 2005 1.30
12 Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 2004 1.24
13 Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol 2006 1.22
14 Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 2010 1.22
15 Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 2010 1.21
16 Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 2009 1.16
17 Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings. Dev Neurosci 2009 1.14
18 Sleep problems in children with prenatal substance exposure: the Maternal Lifestyle study. Arch Pediatr Adolesc Med 2010 1.12
19 Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit 2009 1.10
20 Parenting intervention for externalizing behavior problems in children born premature: an initial examination. J Dev Behav Pediatr 2010 1.10
21 Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicol Teratol 2004 1.09
22 The combined effects of prenatal drug exposure and early adversity on neurobehavioral disinhibition in childhood and adolescence. Dev Psychopathol 2011 1.09
23 Maternal depression and neurobehavior in newborns prenatally exposed to methamphetamine. Neurotoxicol Teratol 2008 1.07
24 Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse 2007 1.05
25 Placenta-imprinted gene expression association of infant neurobehavior. J Pediatr 2011 1.05
26 Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 2007 1.04
27 Patterning in placental 11-B hydroxysteroid dehydrogenase methylation according to prenatal socioeconomic adversity. PLoS One 2013 1.03
28 The effect of parenting stress on child behavior problems in high-risk children with prenatal drug exposure. Child Psychiatry Hum Dev 2008 1.03
29 Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics 2012 1.03
30 Global and gene-specific DNA methylation across multiple tissues in early infancy: implications for children's health research. FASEB J 2014 1.02
31 Atypical cry acoustics in 6-month-old infants at risk for autism spectrum disorder. Autism Res 2012 1.00
32 Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 2011 1.00
33 Fetal effects of psychoactive drugs. Clin Perinatol 2009 0.99
34 Interactions between maternal characteristics and neonatal behavior in the prediction of parenting stress and perception of infant temperament. J Pediatr Psychol 2005 0.99
35 Vagal tone as a resilience factor in children with prenatal cocaine exposure. Dev Psychopathol 2007 0.98
36 The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. Am J Perinatol 2011 0.98
37 Violence and delinquency, early onset drug use, and psychopathology in drug-exposed youth at 11 years. Ann N Y Acad Sci 2006 0.97
38 Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J Dev Behav Pediatr 2008 0.97
39 Small for gestational age and higher birth weight predict childhood obesity in preterm infants. Am J Perinatol 2010 0.96
40 Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 2011 0.96
41 Clinical use of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 2004 0.95
42 Comparison of motor self-regulatory and stress behaviors of preterm infants across body positions. Am J Occup Ther 2003 0.91
43 Placental HTR2A methylation is associated with infant neurobehavioral outcomes. Epigenetics 2013 0.91
44 Major depressive disorder during pregnancy and emotional attachment to the fetus. Arch Womens Ment Health 2011 0.89
45 Growth trajectories of preterm infants: birth to 12 years. J Pediatr Health Care 2008 0.88
46 Serial pediatric symptom checklist screening in children with prenatal drug exposure. J Dev Behav Pediatr 2011 0.88
47 Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction 2012 0.88
48 Variations of NICU sound by location and time of day. Neonatal Netw 2010 0.88
49 Prenatal methamphetamine exposure and inhibitory control among young school-age children. J Pediatr 2012 0.87
50 Novel biomarkers of prenatal methamphetamine exposure in human meconium. Ther Drug Monit 2009 0.87
51 Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS. J Child Adolesc Psychiatr Nurs 2013 0.87
52 Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychol Addict Behav 2012 0.86
53 Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res 2013 0.85
54 Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Matern Child Health J 2013 0.84
55 Prenatal cocaine exposure and childhood obesity at nine years. Neurotoxicol Teratol 2010 0.84
56 Subcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure. Dev Neurosci 2012 0.84
57 An initial investigation of baseline respiratory sinus arrhythmia as a moderator of treatment outcome for young children born premature with externalizing behavior problems. Behav Ther 2012 0.84
58 Long-term impact of maternal substance use during pregnancy and extrauterine environmental adversity: stress hormone levels of preadolescent children. Pediatr Res 2011 0.84
59 Reconceptualizing in a dual-system model the effects of prenatal cocaine exposure on adolescent development: a short review. Int J Dev Neurosci 2011 0.84
60 Mother-infant consultation during drug treatment: research and innovative clinical practice. Harm Reduct J 2008 0.84
61 Prenatal cocaine exposure and small-for-gestational-age status: effects on growth at 6 years of age. Neurotoxicol Teratol 2011 0.83
62 Prenatal cocaine exposure and BMI and blood pressure at 9 years of age. J Hypertens 2010 0.83
63 Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures. Pediatrics 2012 0.83
64 Risk-taking behavior among adolescents with prenatal drug exposure and extrauterine environmental adversity. J Dev Behav Pediatr 2013 0.83
65 Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol 2012 0.83
66 Services used by perinatal substance-users with child welfare involvement: a descriptive study. Harm Reduct J 2010 0.82
67 Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry Hum Dev 2012 0.82
68 Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 2012 0.82
69 Cortisol reactivity to social stress as a mediator of early adversity on risk and adaptive outcomes. Child Dev 2014 0.81
70 Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depress Anxiety 2012 0.80
71 Evidence-based intervention for young children born premature: preliminary evidence for associated changes in physiological regulation. Infant Behav Dev 2012 0.80
72 New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clin Chem 2010 0.80
73 Physiological correlates of neurobehavioral disinhibition that relate to drug use and risky sexual behavior in adolescents with prenatal substance exposure. Dev Neurosci 2014 0.79
74 Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero. Epigenetics 2015 0.79
75 Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. J Stud Alcohol Drugs 2013 0.79
76 Prenatal substance exposure: neurobiologic organization at 1 month. J Pediatr 2013 0.78
77 Expression of imprinted genes in placenta is associated with infant neurobehavioral development. Epigenetics 2015 0.78
78 Parent-Child Interaction Therapy for Children Born Premature: A Case Study and Illustration of Vagal Tone as a Physiological Measure of Treatment Outcome. Cogn Behav Pract 2009 0.77
79 A flexible analysis tool for the quantitative acoustic assessment of infant cry. J Speech Lang Hear Res 2013 0.77
80 Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci 2014 0.77
81 A preliminary study of cortisol reactivity and behavior problems in young children born premature. Dev Psychobiol 2010 0.77
82 Structural brain imaging in children and adolescents following prenatal cocaine exposure: preliminary longitudinal findings. Dev Neurosci 2014 0.76
83 Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology results. Ther Drug Monit 2014 0.75
84 Emotional expression and heart rate in high-risk infants during the face-to-face/still-face. Infant Behav Dev 2013 0.75
85 Building for the future of Rhode Island's newborns. Med Health R I 2010 0.75
86 After family treatment drug court: maternal, infant, and permanency outcomes. Child Welfare 2010 0.75
87 Prenatal Major Depressive Disorder, Placenta Glucocorticoid and Serotonergic Signaling, and Infant Cortisol Response. Psychosom Med 2016 0.75
88 A care coordination program for substance-exposed newborns. Child Welfare 2011 0.75
89 Prenatal cocaine exposure: cardiorespiratory function and resilience. Ann N Y Acad Sci 2006 0.75
90 Vulnerable infants program of Rhode Island: promoting permanency for substance-exposed infants. Child Welfare 2010 0.75